Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
CITALOPRAM HYDROBROMIDE
Chanelle Medical
N06AB04
CITALOPRAM HYDROBROMIDE
20 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
citalopram
Not Marketed
2006-07-07
ID: PL 106/107/108M (IRL NATIONAL) VERSION: 08 EFFECTIVE DATE: Page 1 of 12 PACKAGE LEAFLET-: INFORMATION FOR THE USER CITALOPRAM 10 MG, 20 MG AND 40 MG FILM-COATED TABLETS CITALOPRAM (AS HYDROBROMIDE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Citalopram is and what it is used for 2. What you need to know before you take Citalopram 3. How to take Citalopram 4. Possible side effects 5. How to store Citalopram 6. Contents of the pack and other information 1. WHAT CITALOPRAM IS AND WHAT IT IS USED FOR? HOW DOES CITALOPRAM WORK? Citalopram belongs to a group of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs).. These medicines act on the serotonin-system in the brain by increasing the serotonin level. Disturbances in the serotonin-system are considered an important factor in the development of depression and related diseases. WHAT IS CITALOPRAM USED FOR? Citalopram Film-Coated Tablets contains citalopram and is used for the treatment of depression and, when you feel better, to help prevent these symptoms recurring. Further, Citalopram is used for long-term treatment to prevent the occurrence of new depressive episodes in patients who have recurrent depression. ID: PL 106/107/108M (IRL NATIONAL) VERSION: 08 EFFECTIVE DATE: Page 2 of 12 Citalopram is also beneficial in relieving symptoms in patients prone to panic attacks. Ask your doctor if you have any questions about why Citalopram has been prescribed for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CITALOPRAM FILM-COATED TABLETS Baca dokumen lengkap
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Citalopram 20mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablets contains citalopram hydrobromide corresponding to 20 mg citalopram base Also contains 15.0 mg lactose monohydrate per tablet. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White to off-white coloured, oval, film-coated tablets with a score line on one side. The film-coated tablet can be divided into equal halves 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Citalopram is also indicated in the treatment of panic disorder with or without agoraphobia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY _Depression_ _Adults:_ Citalopram should be administered as a single oral dose of 20mg daily. Depending on individual patient response, the dose may be increased to a maximum of 40mg daily. _Duration of Treatment_ The antidepressant effect usually sets in after 2 to 4 weeks. Treatment with antidepressants is symptomatic and must therefore be continued for an appropriate length of time, usually up to 6 months after recovery in order to prevent relapse. In patients with recurrent depression (unipolar) maintenance therapy may need to be continued for a number of years to prevent new episodes. _Panic Disorder_ _Adults:_ A single oral dose of 10mg is recommended for the first week before increasing the dose to 20mg daily. Depending on individual patient response, the dose may be increased to a maximum of 40 mg daily. Duration of Treatment H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ Baca dokumen lengkap